Literature DB >> 25598152

Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).

Maria João Matos1, Saleta Vazquez-Rodriguez, Eugenio Uriarte, Lourdes Santana.   

Abstract

INTRODUCTION: Chalcones are one of the major classes of naturally occurring compounds. A large number of synthetic routes have been reported for the synthesis of chalcones, the most classical and general being the Claisen-Schmidt condensation. Chalcones and their derivatives have a huge importance in medicinal chemistry, displaying a wide range of important pharmacological activities. AREAS COVERED: The authors provide an overview of the recent scientific reports describing the obtention and study of new chalcones. The review emphasizes the rationale behind the natural sources, the discovery, the design, the synthesis, the biological activities and the study of structure-activity relationships of the new chalcone derivatives. The article is based on the literature published from June 2011 - 2014 related to the development of this family of compounds. The patents presented in this review have been collected from multiple electronic databases including Scifinder, Espacenet and Mendeley. EXPERT OPINION: Although a great number of extracts containing chalcones have been published in bibliographic sources, the potential of this scaffold could be deeply studied in many different areas in which almost nothing has been described. A lot of work should be done to reach the potency and safety requirements needed to develop new chemical entities as new drugs.

Entities:  

Keywords:  chalcones; natural extracts; pharmacological properties; synthesis

Mesh:

Substances:

Year:  2015        PMID: 25598152     DOI: 10.1517/13543776.2014.995627

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  15 in total

Review 1.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

2.  Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.

Authors:  Yiqiang Wang; Andreas Hedblom; Steffi K Koerner; Mailin Li; Finith E Jernigan; Barbara Wegiel; Lijun Sun
Journal:  Bioorg Med Chem Lett       Date:  2016-10-24       Impact factor: 2.823

3.  In-silico analysis of substituent effect on the static first order hyperpolarizability of electron donating mono substituted Chalcone derivatives.

Authors:  Lakshmi C S Nair; S Balachandran; D Arul Dhas; I Hubert Joe
Journal:  J Mol Model       Date:  2018-05-04       Impact factor: 1.810

4.  Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones.

Authors:  Krystyna Okoniewska; Marek T Konieczny; Krzysztof Lemke; Tomasz Grabowski
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

5.  Hydroxychalcone inhibitors of Streptococcus mutans glucosyl transferases and biofilms as potential anticaries agents.

Authors:  Bhavitavya Nijampatnam; Luke Casals; Ruowen Zheng; Hui Wu; Sadanandan E Velu
Journal:  Bioorg Med Chem Lett       Date:  2016-06-14       Impact factor: 2.823

Review 6.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

7.  Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method.

Authors:  Dhawal Raghuvanshi; Gregory Nkepang; Alamdar Hussain; Hooman Yari; Vibhudutta Awasthi
Journal:  J Pharm Anal       Date:  2016-09-28

8.  YJI-7 Suppresses ROS Production and Expression of Inflammatory Mediators via Modulation of p38MAPK and JNK Signaling in RAW 264.7 Macrophages.

Authors:  Hye Jin Oh; Til Bahadur Thapa Magar; Nirmala Tilija Pun; Yunji Lee; Eun Hye Kim; Eung-Seok Lee; Pil-Hoon Park
Journal:  Biomol Ther (Seoul)       Date:  2018-03-01       Impact factor: 4.634

9.  Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders.

Authors:  Payyalot Koyiparambath Vishal; Jong Min Oh; Ahmed Khames; Mohamed A Abdelgawad; Aathira Sujathan Nair; Lekshmi R Nath; Nicola Gambacorta; Fulvio Ciriaco; Orazio Nicolotti; Hoon Kim; Bijo Mathew
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

10.  A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells.

Authors:  Saiyang Zhang; Tingyu Li; Li Zhang; Xiangyu Wang; Hangqi Dong; Lili Li; Dongjun Fu; Yongchun Li; Xiaolin Zi; Hong-Min Liu; Yanbing Zhang; Hongde Xu; Cheng-Yun Jin
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.